Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications

Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials

(2022) Vincent Wai-Sun Wong et al.   Clinical Gastroenterology and Hepatology

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis

(2021) Emmanuel Anandraj Selvaraj et al.   JOURNAL OF HEPATOLOGY

Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement

(2021) Jerome Boursier et al.   DIABETES & METABOLISM

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications

(2020) Stefano Ciardullo et al.   BMJ Open Diabetes Research & Care

Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study

(2020) Oumarou Nabi et al.   GASTROENTEROLOGY

Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis

(2020) Yasaman Vali et al.   JOURNAL OF HEPATOLOGY

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Transient Versus 2‐Dimensional Shear‐Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD

(2020) Christophe Cassinotto et al.   HEPATOLOGY

Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

(2020) Margarita Papatheodoridi et al.   JOURNAL OF HEPATOLOGY

Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease

(2019) Vincent Wai-Sun Wong et al.   GUT

New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

(2019) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis

(2019) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease

(2019) Charmaine Fu et al.   Clinical Gastroenterology and Hepatology

Molecular form and concentration of serum α2-macroglobulin in diabetes

(2019) Sonomi Yoshino et al.   Scientific Reports

Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease

(2018) Luis C. Bertot et al.   LIVER INTERNATIONAL

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

(2016) Stuart McPherson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study

(2015) Edith M. Koehler et al.   HEPATOLOGY

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015)   JOURNAL OF HEPATOLOGY

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology